k.varga
Submits third-party assay reports on material purchased directly. Based in Turku.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.54%
n=8
Suppliers covered
7
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041603 | CJC-1295 (no DAC) | QSC | QSC-2606-V7416 | PeptideMeter | 2026-Q3 | 98.43 | 4.20 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042583 | BPC-157 | HJ | HJ-2511-U6485 | VendorInvestigate | 2026-Q2 | 98.79 | 5.98 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043277 | L-Glutathione (reduced) | CPC | CPC-2602-D1499 | Nordanalyt | 2026-Q1 | 98.25 | 7.94 | — | Laboratory-retained | 0 | FAIL |
| AX-2026-043068 | Exenatide | KP | KP-2511-W5891 | Janoshik | 2026-Q1 | 98.58 | 3.70 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020244 | Ipamorelin | GGPeps | GGPE-2411-B1929 | Janoshik | 2025-Q2 | 99.05 | 4.99 | 93.0 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005328 | Tirzepatide | QST | QST-2409-K5786 | VendorInvestigate | 2024-Q4 | 98.50 | 6.10 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005006 | Semaglutide | KP | KP-2405-C4939 | Janoshik | 2024-Q3 | 98.01 | 4.35 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004359 | Leuprolide | FGP | FGP-2406-N8689 | Janoshik | 2024-Q3 | 99.53 | 3.83 | — | Buyer-sourced | 0 | PASS |